Shire (SHP)

 

SHP Share PerformanceMore

52 week high5,377.0 20/09/16
52 week low2,707.0 13/07/16
52 week change 542.5 (12.67%)
4 week volume47,256,354 26/04/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Broker views: Pharma and mining

Equity analysts at HSBC have downgraded their investment rating on Shire Pharmaceuticals (LON:SHP) to 'reduce' (from ...

Broker Forecast - HSBC issues a broker note on Shire PLC

HSBC today downgrades its investment rating on Shire PLC (LON:SHP) to reduce (from hold) and cut its price target to 44...

FTSE falls on Shell and weak miners

As Royal Dutch Shell (RDSB) traded ex-dividend and oil prices came under pressure, shares in the oil giant dropped sharpl...

Shire receives positive lanadelumab results

Shire has announced positive topline Phase 3 results for the HELP study that evaluated the efficacy and safety of subcutan...

Positive lanadelumab topline Phase 3 results

Shire?s Investigational Treatment Lanadelumab Reduces Hereditary Angioedema Monthly Attack Rate by 87% Versus Placebo in Phase 3 26-week Pivotal Trial Significant reduction in monthly Hereditary Angioedema (HAE) attack rate with infrequent subcutaneous administration Data to serve as basis for U.S. BLA filing expected in Q4 2017 to Q1 2018 Shire to host...

Broker Forecast - Deutsche Bank issues a broker note on Shire PLC

Deutsche Bank today reaffirms its buy investment rating on Shire PLC (LON:SHP) and cut its price target to 6100p (from ...

Director/PDMR Shareholding

Director/PDMR Shareholding May 3, 2017 ? Shire plc (LSE: SHP, NASDAQ: SHPG) (the ?Company?) Notification of transactions by person discharging managerial responsibilities 1. Details of the person discharging managerial responsibilities (?PDMR?) / person closely associated them (?PCA?) a) Name Matt Walker 2. Reason for the notification a) Position / status Head...

UK manufacturing hits three-year high

UK manufacturing activity rose to a three-year high in April. The purchasing managers' index increased to 57.3, up from M...

Latest discussion posts More

  • Shire news

    Shire has announced positive topline Phase 3 results for the HELP study that evaluated the efficacy and safety of subcutaneously administered lanadelumab versus placebo over 26 ...
    18-May-2017
    Proverbs 26 vs 5
  • Re: Good growth prospects IMO

    If it is Trump worries that were holding this stock back then hopefully they've been dispelled by his seeming inability to really implement anything that he'd like to. These ...
    3-May-2017
    Tight Yorkshireman
  • Re: Good growth prospects IMO

    Yes, I think it has mainly been the threats from Trump to crack down on pharmaceutical high prices that have been holding these back. Whether or not he will ever do anything is ...
    2-May-2017
    DaveHughes

Users' HoldingsMore

Users who hold Shire also hold..
GLAXOSMITHKLINE31%
LLOYDS GRP.28%
NATIONAL GRID26%
VODAFONE GRP.25%
BP23%

Codes & Symbols

ISINJE00B2QKY057
SymbolsSHP, LSE:SHP, SHP.L, SHP:LN, LON:SHP, XLON:SHP